Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old (NCT04748601)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age
🩺 Plain-English Summary (8th-Grade Level)
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Who can join: Review the eligibility criteria below.
Location: Upsher-Smith Clinical Trial Site #5 — Birmingham, Alabama
Age range: 6 Years to 11 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Upsher-Smith Clinical Trial Site #5 — Birmingham, Alabama
- Upsher-Smith Clinical Trial Site #15 — La Jolla, California
- Upsher-Smith Clinical Trials Site #3 — Aurora, Colorado
- Upsher-Smith Clinical Trial Site #1 — Stamford, Connecticut
- Upsher-Smith Clinical Trial Site #12 — Loxahatchee Groves, Florida
- Upsher-Smith Clinical Trial Site #8 — Orlando, Florida
- Upsher-Smith Clinical Trial Site #14 — Tampa, Florida
- Upsher-Smith Clinical Trial Site #2 — Ann Arbor, Michigan
- Upsher-Smith Clinical Trial Site #11 — Jackson, Mississippi
- Upsher-Smith Clinical Trial Site #10 — Bridgeton, Missouri
- Upsher-Smith Clinical Trial Site #4 — Cincinnati, Ohio
- Upsher-Smith Clinical Trial Site #6 — Portland, Oregon
- Upsher-Smith Clinical Trials Site #7 — Springfield, Oregon
- Upsher-Smith Clinical Trial Site #13 — McAllen, Texas
- Upsher-Smith Clinical Trial Site #9 — Huntington, West Virginia
📞 Contact the Study Coordinator
Phone: (877) 302-2879
Email: uslinfo@upsher-smith.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine Disorders
- EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization — Tacoma, Washington
- Using Virtual Reality to Teach Mindfulness to People With Migraine — Boston, Massachusetts
- EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine — Tacoma, Washington
- MMA Embolization for Refractory Chronic Migraine — Walnut Creek, California
Explore by condition: All Migraine Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.